As of Oct 26, 2026: Vera Therapeutics (VERA) announced the FDA's approval of atacicept on Aug 10, 2026; its PDUFA date was Jul 7, 2026. Its Quality Score is -4. Scores as of 10:16 PM ET, 15 minutes behind.

VERA FDA decision on Atacicept

Vera Therapeutics · PDUFA date

OutcomeApprovedannounced Aug 10 Quality Score-4Poor

Cash runway5quarters of cash

The FDA's decision

Approved. Vera Therapeutics announced the FDA's approval of atacicept on Aug 10, 2026.

“License Application (BLA) for the accelerated approval of atacicept in adult patients with IgA Nephropathy (IgAN) with a Prescription Drug User Fee Act (PDUFA) date of July 7, 2026”

PDUFA date, Jul 7, 2026. As Vera Therapeutics stated in its 8-K of May 7, 2026 (the filing).

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert when VERA files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How VERA's stock moved on its past FDA days, for Pro members. Pro members also see the members' FDA calendar with filters and optional alerts.

More on VERA and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.